Latest Breaking News On - Marie svensson - Page 1 : vimarsana.com

Alligator Bioscience AB: Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update

New study hopes to find answers to why Covid-19 can give people serious eye problems - Radio Sweden

A long-lasting loss of sense of smell and taste are some of the now well-established ailments of people hit by post-Covid. But some people are also reporting .

Alligator Bioscience AB: Year End report January-December 2021

STOCKHOLM, Feb. 11, 2022 /PRNewswire/ OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our pre-clinical

Alligator Bioscience AB: Year End report January-December 2021

/PRNewswire/ OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our.

Alligator Bioscience AB: Year End report January-December 2021

/PRNewswire/ OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our.

Alligator Bioscience AB: Interim report January-September 2021

/PRNewswire/ First Patient Dosed in Optimize-1 Phase II "We continued to make great strides in the third quarter of 2021. The first patient was dosed in.

Alligator Bioscience AB: Interim report January-June 2021

Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021

/PRNewswire/ Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the company this day. In light of.

Alligator Bioscience AB: Interim report January-March 2021

                                                                                                           High activity during the first quarter So far, 2021 has been characterized by high activity, with a research collaboration that validates our Discovery concept, and good progress of our clinical programs, with ATOR-1017 and mitazalimab entering clinical efficacy studies this year. Malin Carlsson, Interim CEO Alligator Bioscience AB SIGNIFICANT EVENTS JANUARY-MARCH Pipeline: New preclinical data were released in an abstract for a poster presentation at the AACR Annual Meeting 2021, demonstrating that mitazalimab synergizes with chemotherapy. Company: Søren Bregenholt was appointed as new CEO to strengthen Alligator s business development activities and clinical progress on an international level. Oversubscribed rights issue generated proceeds of SEK 86 milli

Alligator Bioscience AB: Interim report January-March 2021